Skip to main content

Advertisement

Table 3 Comparison between survivors and non-survivors with IM

From: Invasive mycoses in patients with connective tissue disease from Southern China: clinical features and associated factors

Characteristics Survivor (n = 22) Non-survivor (n = 10) P value
Demographic characteristics
 Sex, male to female 4:18 3:7 0.45
 Age, years, mean ± SD 41.6 ± 15.6 44.2 ± 16.8 0.68
 Diabetes mellitus, n (%) 2(9.1) 2(20.0) 0.39
 Interstitial pneumonia, n (%) 4(18.2) 2(20.0) 0.90
 Nephritis, n (%) 12(54.5) 7(70.0) 0.41
Laboratory data
 Leukopenia, n (%) 1(4.5) 3(30.0) 0.04*
 Lymphopenia, n (%) 13(59.1) 10(100) 0.02*
 Anemia, n (%) 12(54.5) 8(80.0) 0.17
 Hypoalbuminemia, n (%) 14(63.6) 9(90.0) 0.12
 Elevated serum creatinine, n (%) 6(27.3) 7(70.0) 0.02*
 Co-infection, n (%) 4(18.2) 7(70.0) 0.004*
 Co-infection with multiple agents, n (%) 1(4.5) 2(20.0) 0.22
 Co-infection in multiple sites, n (%) 0(0) 5(50.0) < 0.001*
Treatments prior to IM
 Median-to-high dose of GC, n (%) 7(31.8) 4(40.0) 0.65
 CYC, n (%) 4(18.2) 5(50.0) 0.06
 MMF, n (%) 1(4.5) 2(20.0) 0.16
  1. CYC cyclophosphamide, GC glucocorticoid, IM invasive mycoses, MMF mycophenolate mofetil, SD standard deviation
  2. *Significant